Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 100 /hr
Hire Manideepthi P.
United States
USD 100 /hr
Certified Clinical Research Professional | Expert in Translational Research, Public Health, and Clinical Trials Mgt
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Medical Writing,
Non-Medical Regulatory Writing,
Technical Writing
Research
Scientific and Technical Research,
Secondary Data Collection
Consulting
Healthcare Consulting,
Regulatory Consulting
Work Experience
Translational Research Manager
Vanderbilt University Medical Center
June 2022 - Present
Translational Research Manager
Vanderbilt University Medical Center
June 2022 - Present ![]()
Research Program Manager
Vanderbilt University Medical Center
May 2018 - May 2022 ![]()
Clinical/Translational Research Coordinator IV
Vanderbilt University Medical Center
August 2015 - April 2018 ![]()
Clinical/Translational Research Coordinator I
Vanderbilt University Medical Center
May 2014 - July 2015 ![]()
Research Analyst II
Vanderbilt University Medical Center
July 2009 - April 2014 ![]()
Education
Master of Public Health, MPH
Western Kentucky University
August 2007 - May 2010 ![]()
Bachelor of Medicine and Bachelor of Surgery, MBBS
Dr NTR University of Health Sciences
September 2001 - July 2007 ![]()
Certifications
Publications
JOURNAL ARTICLE
Julia Gargano, McClung N, Lewis RM, Park IU, Whitney E, Castilho JL, Pemmaraju M, Niccolai LM, Brackney M, DeBess E, et al. (2022). HPV type-specific trends in cervical precancers in the United States, 2008 to 2016 . International journal of cancer.
Sackey ENS, Pemmaraju M, Griffin MR, Castilho JL (2022). Impact of prior underinsurance on cervical cancer screening among Davidson County, Tennessee, women diagnosed with invasive cervical cancer, 2008-2018 . BMC women's health.
Jaimie Z. Shing, Marie R. Griffin, Rachel S. Chang, Alicia Beeghly-Fadiel, Staci L. Sudenga, James C. Slaughter, Manideepthi Pemmaraju, Edward F. Mitchel, Pamela C. Hull(2022). Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population . American Journal of Preventive Medicine. 62. (3). p. 395--403. Elsevier {BV}
Jaimie Z. Shing, Alicia Beeghly-Fadiel, Marie R. Griffin, Rachel S. Chang, Staci L. Sudenga, James C. Slaughter, Manideepthi Pemmaraju, Edward F. Mitchel, Pamela C. Hull(2021). The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age–Period–Cohort Analysis . Cancers. 13. (16). p. 4215. {MDPI} {AG}
Jaimie Shing, Alicia Beeghly-Fadiel, Marie R. Griffin, Rachel S. Chang, Staci Sudenga, James C. Slaughter, manideepthi pemmaraju, Edward F. Mitchel, Pamela C. Hull (2021). The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age–Period–Cohort Analysis . Cancers.
(2021). Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008-2016 . Journal of lower genital tract disease.
(2020). Improving Cervical Precancer Surveillance: Validity of Claims-Based Prediction Models in ICD-9 and ICD-10 Eras . JNCI cancer spectrum.
(2019). Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015 . International journal of cancer.
(2019). Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016 . MMWR. Morbidity and mortality weekly report.
(2019). Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination . Papillomavirus research (Amsterdam, Netherlands).
(2019). Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008-2015 . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
(2018). Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era . American journal of preventive medicine.
(2015). Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012 . Emerging infectious diseases.
(2015). Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012 . Vaccine.
(2014). HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States . Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
(2012). Human papillomavirus genotypes in high-grade cervical lesions in the United States . The Journal of infectious diseases.
(2011). The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions . Cancer causes & control : CCC.